Samrat Pharmachem

351.50
-3.00
(-0.85%)
Market Cap
108.57
Eps
7.00
PE Ratio (TTM)
16.94
Dividend Yield
0.28
Industry
Healthcare
52 Week High
646.00
52 Week low
320.00
PB Ratio
1.58
Debt to Equity
0.21
Sector
Pharmaceuticals
Add Ratio

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Growth Rate
Revenue Growth
-9.03 %
Net Income Growth
-86.75 %
Cash Flow Change
199.68 %
ROE
-87.36 %
ROCE
-86.90 %
EBITDA Margin (Avg.)
-82.65 %

Yearly Financial Results

Annual Financials
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
TTM
Revenue
48
62
71
93
112
138
180
222
311
283
297
Expenses
46
61
67
87
108
131
170
198
287
279
288
EBITDA
2
1
4
6
4
7
9
25
24
4
9
Operating Profit %
2 %
2 %
5 %
6 %
3 %
5 %
5 %
11 %
8 %
1 %
2 %
Depreciation
0
0
0
0
0
0
1
1
1
1
1
Interest
1
1
1
1
1
1
1
1
1
1
1
Profit Before Tax
1
0
3
5
2
6
7
24
23
3
8
Tax
0
0
1
2
1
2
2
6
6
0
2
Net Profit
0
0
2
3
2
4
5
17
17
2
7
EPS in ₹
1.02
0.97
5.68
10.41
4.97
13.71
17.26
55.62
53.83
7.00
20.90

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Total Assets
26
36
36
41
40
58
57
85
117
122
Fixed Assets
7
7
7
7
7
7
9
10
11
11
Current Assets
19
28
28
33
33
50
47
71
99
103
Capital Work in Progress
0
0
0
0
0
1
0
0
0
0
Investments
0
2
0
0
0
0
0
0
2
3
Other Assets
19
27
29
34
33
50
48
75
104
108
Total Liabilities
26
36
36
41
40
58
57
85
117
122
Current Liabilities
12
21
19
21
19
34
27
37
53
56
Non Current Liabilities
1
2
2
1
1
0
0
1
0
0
Total Equity
14
14
15
19
20
24
30
47
63
65
Reserve & Surplus
10
11
12
15
17
21
27
44
60
62
Share Capital
3
3
3
3
3
3
3
3
3
3

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Net Cash Flow
-0
-0
-1
-1
1
-1
0
15
-3
-2
Investing Activities
0
-2
1
-2
2
-2
-3
-1
-3
-0
Operating Activities
-1
-0
-3
0
2
-1
5
18
-9
9
Financing Activities
0
2
1
2
-4
2
-2
-2
10
-11

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Promoter
49.30 %
49.30 %
49.30 %
49.65 %
49.65 %
49.65 %
49.54 %
48.64 %
48.64 %
48.64 %
48.64 %
48.64 %
48.64 %
48.64 %
48.95 %
49.09 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
3.24 %
3.24 %
3.24 %
3.24 %
DIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.22 %
0.22 %
0.22 %
0.00 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
42.44 %
42.93 %
42.96 %
41.06 %
37.41 %
36.70 %
37.09 %
37.89 %
38.48 %
38.81 %
42.58 %
42.61 %
41.69 %
40.79 %
41.34 %
41.95 %
No of Share Holders
2,885
5,189
5,214
4,846
4,675
4,768
7,390
8,040
8,039
7,938
8,445
8,065
7,478
7,169
6,984
6,844

Dividend History

Dividends per share (FY)
Dividend yield (FY) %

No dividends have been distributed by the company in the past 10 years

Competitors LTP Market Cap (₹ Cr.) P/E Ratio Revenue (₹ Cr.) YoY Revenue Growth % Net Profit (₹ Cr.) YoY Profit Growth % RSI
1,752.75 4,20,543.44 35.94 49,887.20 12.06 9,648 13.77 44.79
6,123.50 1,62,559.68 78.25 8,184.00 0.89 1,600 64.53 60.08
1,436.80 1,16,037.99 23.45 26,520.70 14.17 4,155 47.38 46.67
3,114.70 1,05,415.60 56.43 10,785.70 11.59 1,656 13.54 35.94
2,483.00 1,02,440.36 51.56 10,615.60 19.57 1,942 -16.38 42.73
1,227.55 1,02,428.11 18.95 28,905.40 12.36 5,578 1.69 41.25
2,185.10 99,683.73 36.66 20,141.50 19.94 1,936 73.53 56.12
977.00 98,309.06 22.90 19,831.50 13.82 3,831 29.92 51.89
1,191.75 69,217.03 18.82 29,559.20 17.55 3,169 8.66 48.98
5,117.95 61,192.77 28.08 12,978.40 9.84 1,812 14.16 43.89

Corporate Action

Technical Indicators

RSI(14)
Neutral
41.25
ATR(14)
Volatile
17.54
STOCH(9,6)
Neutral
30.39
STOCH RSI(14)
Neutral
41.70
MACD(12,26)
Bullish
1.44
ADX(14)
Weak Trend
17.60
UO(9)
Bearish
48.18
ROC(12)
Uptrend And Accelerating
0.18
WillR(14)
Oversold
-81.50